Lupus & Connective Tissue Diseases
Latest News
Autoimmune Skin Diseases Linked To Risk Of Adverse Pregnancy Outcomes
The three most common autoimmune skin diseases in the study cohort were vitiligo (30%), alopecia areata (30%), and cutaneous lupus erythematosus (...
From the Journals
COVID vaccination protects B cell–deficient patients through T-cell responses
The findings demonstrate how vaccine-induced T-cell responses could potentially reduce COVID-19 severity, the authors write.
From the Journals
Low-dose methotrexate carries higher risk for older patients with CKD
Adverse event data showed an increased risk of myelosuppression, sepsis, pneumotoxic effects, or hepatotoxic effects.
Guidelines
Conditional recommendations rule in new SARD-associated interstitial lung disease guidelines
“Clinicians must retain the latitude to prescribe medications based on individual patient factors and preferences.”
Conference Coverage
Risks quantified in medically optimized pregnancy with lupus
Patients who were not medically optimized for pregnancy were three times more likely to experience preterm birth and preeclampsia.
Conference Coverage
Benralizumab proves noninferior to mepolizumab for rare vasculitis, EGPA
“I anticipate that the drug will be approved for use in EGPA, providing another option for treating this complicated multisystem eosinophilic-...
Opinion
Diagnosing patients with sarcoidosis
Sarcoidosis should always be part of the differential when you see lymphopenia.
Conference Coverage
Vasculitis confers higher risk for adverse pregnancy outcomes
“This study should help inform our family planning conversations with our vasculitis patients,” Dr. Lindsay S. Lally said.
Conference Coverage
Caution raised on reduced-dose steroids in rare vasculitides GPA, MPA
A real-world analysis finds that some patients who receive reduced-dose glucocorticoids may have a higher risk of poor outcomes.
Conference Coverage
Pregnancy in rheumatic disease quadruples risk of cardiovascular events
Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than...
Conference Coverage
Pregnancies with low anti-SSA/Ro autoantibody levels: Forgo fetal heart rhythm monitoring?
The ongoing prospective multicenter trial is the largest of its kind.